Clinical trial
Omegaven in Patients With Rheumatoid Arthritis (ORA-Trial)
NCT00412256 · Humanis Klinikum Niederosterreich, Other · Completed
Key facts
| NCT number | NCT00412256 |
|---|---|
| Title | Omegaven in Patients With Rheumatoid Arthritis (ORA-Trial) |
| Official title | Clinical Trial to Evaluate the Effect of Parenteral Supplementation With Omega-3-Fatty Acids in Patients With Rheumatoid Arthritis |
| Lead sponsor | Humanis Klinikum Niederosterreich, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | Omegaven (10% fish-oil emulsion, Fresenius-Kabi) |
| Enrollment | 60 |
| Start date | Sep 1, 2004 |
| Completion | Nov 1, 2006 |
| First posted | Dec 18, 2006 |
| Last update posted | Dec 18, 2006 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: